Limited coverage drugs – deferasirox

Last updated on August 20, 2024

Generic name

deferasirox

Strength

Tablet, dispersible: 125 mg, 250 mg, 500 mg

Tablet, oral: 90 mg, 180 mg, 360 mg

Form

tablet (dispersible and oral)

Special Authority criteria

Approval period  

Treatment of transfusion-dependent conditions where iron chelation therapy is required, according to established criteria*, and when prescribed by a hematologist.

Initial request: 1 year

Renewal request: 1 year

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)

* Click on the Special Authority Form below for full criteria: